Emphysematous change with scleroderma-associated interstitial lung disease: The potential contribution of vasculopathy?
BMC Pulmonary Medicine Feb 17, 2018
Yamakawa H, et al. - Researchers here describe a new finding characterized by peculiar emphysematous change with systemic sclerosis (SSc)-associated interstitial lung disease (ILD) [(SSc-ILD)]. The identified pulmonary emphysematous changes [low attenuation area (LAA) within interstitial abnormalities on high-resolution computed tomography (HRCT) and destruction of fibrously thickened alveolar walls)] represented specific and novel radio-pathological features of SSc-ILD. Notably, via facilitating destruction in the fibrously thickened alveolar walls, peripheral vasculopathy may result in emphysematous change in SSc-ILD.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries